BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace

Veralox Therapeutics

Veralox Therapeutics logo

Founded
2017
Clinical Trials
2
Publications
1

Technologies

AI Companies (Drug Discovery) Pharmaceutical and Drug Discovery

Veralox Therapeutics develops small molecule therapeutics that treat the underlying pathologies of thrombosis and type 1 diabetes. Based on an understanding of the molecular mechanisms of these diseases, these efforts will lead to new treatment paradigms and better outcomes for patients.

Become a Member to view additional information about this company